Dermatology

Sneak Peek: 2024 Fall Clinical Dermatology Conference for PAs and NPs – Dermatology Times

The 2024 Fall Clinical Dermatology Conference for PAs and NPs kicks off this weekend in Scottsdale, Arizona. Dermatology Times will be on-site bringing clinical insights from leading experts in numerous dermatology treatment specialties presenting to physician assistants and nurse practitioners from around the country.

Dermatology Times will feature interviews throughout the weekend from leaders in dermatology including:

Organizers have planned for the annual conference to provide maximum engagement and value to attendees both in-person and online for some sessions. Stay up-to-date with all conference coverage and new pearls to put into practice from Dermatology Times by subscribing to our email newsletters and following us on Facebook, LinkedIn, and X.

Earlier this week, Dermatology Times published a poll asking what content from the 2024 Fall Clinical Dermatology Conference for PAs and NPs you want to learn and the results are:

Organizers for the 2024 Fall Clinical Dermatology Conference for PAs and NPs have outlined 8 key learning objectives. They say attendees will be better equipped to:

1. Discuss the pathogenesis and optimal management of psoriasis, atopic dermatitis, and acne vulgaris: Attendees will delve into the underlying mechanisms and best treatment practices for these common dermatologic conditions, gaining a deeper understanding that will aid in more effective patient management.

2. Update knowledge regarding recent advances in the safe and effective use of biologic agents for the treatment of dermatologic diseases: With biologics becoming increasingly pivotal in dermatologic care, this objective ensures that practitioners stay abreast of the latest advancements and safety protocols.

3. Enhance the ability to evaluate and incorporate new techniques and uses of dermal fillers and neurotoxins: The conference will cover the latest trends and techniques in cosmetic dermatology, enabling attendees to enhance their aesthetic practice with cutting-edge skills.

4. Identify and describe the indications, contraindications, and evidence-based safety and efficacy profiles of new agents approved for use in the dermatology setting: Participants will receive comprehensive updates on newly approved dermatologic agents, backed by evidence-based safety and efficacy data.

5. Integrate prevention, diagnosis, and management of skin cancer into a clinical setting: Given the rising incidence of skin cancer, this objective emphasizes the importance of integrating robust prevention, diagnostic, and management strategies into clinical practice.

6. Diagnose commonly presented dermatologic disorders: Attendees will refine their diagnostic skills, ensuring they are well-equipped to identify and manage a broad spectrum of dermatologic conditions.

7. Improve my clinical interactions with patients: Effective patient communication is crucial in dermatology. This objective aims to enhance practitioners' abilities to interact empathetically and effectively with their patients.

8. Integrate knowledge to enhance daily dermatologic care: The conference will provide actionable insights that practitioners can immediately apply to elevate the quality of care they provide daily.

View post:

Sneak Peek: 2024 Fall Clinical Dermatology Conference for PAs and NPs - Dermatology Times

Dermatology

QUIZ RECAP: Treatment and Management of Skin Cancer – Dermatology Times

This week we asked the question: How much do you know about the treatment and management of skin cancer?

Haven't taken our quiz yet? Pause before reading below and follow this link to complete it: here.

Below, we recap our fourth and final quiz and the correct answers to each question.

Response options:

Correct response option: Topical imiquimod

Topical imiquimod is employed in treating specific abnormal skin conditions, including actinic keratosis, superficial basal cell carcinoma, and external genital warts. It is believed to modify the immune systems response to aid in the removal of abnormal skin growths and is available under the brand names Aldara and Zyclara, as well as in generic forms.1

Response options:

Correct response option: Wide local excision with 1 cm margins

International clinical guidelines typically suggest 510 mm margins for excising MIS. Despite limited evidence supporting this, the guidelines are fairly consistent. However, due to frequent subclinical extensions, especially in the lentigo maligna (LM) subtype, wider margins are often needed to ensure complete removal.2

Response options:

Correct response option: Adjuvant immunotherapy or targeted therapy may be considered

Adjuvant therapy given after surgery may reduce the risk of melanoma recurrence in patients with stage IIB-IV melanoma. Its purpose is to target and eliminate any remaining microscopic melanoma cells, potentially improving the overall chance of a cure by enhancing the immune system's ability to eradicate residual cancer cells, thereby delaying or preventing the return of melanoma and improving overall survival. Adjuvant therapy is especially considered for patients at high risk of recurrence after the primary treatment has removed all visible tumors.3

Response options:

Correct response option: Vemurafenib

The FDA has approved several medications for advanced melanoma with a BRAF V600 mutation, including:4

Response options:

Correct response option: True

PDT is a noninvasive treatment for small nodular BCCs. It involves applying a photosensitizing agent, such as aminolevulinic acid or methyl aminolevulinate, to the skin. When exposed to visible light, this agent produces reactive oxygen species that destroy cancer cells. PDT also damages the cancer's blood vessels, cutting off its nutrient supply, and may stimulate the immune system to attack the tumor cells.5

References

See the rest here:

QUIZ RECAP: Treatment and Management of Skin Cancer - Dermatology Times

Dermatology

Dermatology Care of Alabama goes the extra mile to give the best care – Hoover Sun

Dermatology Care of Alabama treats all of your skin concerns, regardless of age and skin type, and offers a wide variety of the latest cosmetic and medical-aesthetic treatments.

This is true at our original office in Tuscaloosa, founded in 2017, and at our recently opened office in Hoover, located at 2321 John Hawkins Parkway.

We are thrilled to be a part of the Hoover community and are excited to serve our new patients here. In fact, at Dermatology Care of Alabama, theres nothing more important to us than our patients.

This commitment comes from the founder of the practice, Dr. Robert Bentley, a board-certified dermatologist with nearly 50 years of experience. In addition to being a skilled, experienced physician, Dr. Bentley is very compassionate and truly wants to serve people.

He has instilled in the clinic staff the importance of truly caring for a patient and going the extra mile to see that they have the absolute best care and best experience in our clinic.

We work to make sure our patients feel welcome and comfortable in our clinics, as well.

Dermatology Care of Alabama also seeks to make it as convenient as possible for our patients to see us. When we opened in Tuscaloosa seven years ago, we promised our patients that they would never have to wait weeks or months for an appointment. We make that same commitment to our Hoover patients.

In fact, beginning this summer, we will offer walk-in or same day dermatology visits, in addition to regular appointments. We want to remove any obstacles for patients to receive great care.

That great patient care comes from our outstanding team of well-trained, highly skilled providers, including Dr. Bentley and in the Hoover office Dr. Paul Espy, with decades of experience as a board-certified dermatologist. We have a full-time physician assistant in Hoover, as well.

In addition to general dermatology, we have a full-service Aesthetics Center in Tuscaloosa staffed with full-time, licensed aestheticians specializingin skin care, injectables and RF body sculptingand tightening.

We provide some of the most popular cosmetic and medical-aesthetic treatments in our Hoover office. We offer injectables such as botox and filler in Hoover, as well as Express Laser Hair removal and Opus Plasma Skin Resurfacing.

We are excited to offer these treatments in Hoover using Alma Lasers, which are a highly effective technology with little or no discomfort or downtime for our patients.

We also offer Accent Prime, which uses radio frequency to tighten skin. Accent Prime can treat everything from the neck to the knees. Its a really effective treatment for skin tightening.

Aesthetic dermatology is popular because these treatments are administered directly by or under the supervision of a board-certified dermatologist, so theyre truly medical-aesthetic treatments. Our nurse who performs some of the procedures is highly trained and has thousands of hours of education and training.

The staff at Dermatology Care of Alabama also works hard to help prevent and spread awareness of skin cancer.

When detected early, the survival rate for melanoma, the most serious form of skin cancer, is 99%. Thats why prevention and detection are so important. This includes

non-melanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma

The sooner those cancers are detected, the more effectively we can treat them. We make sure we educate all our patients on what to look for if they suspect they may have a cancerous lesion, and we educate everyone on skin cancer prevention as well.

We can treat many skin cancers in the office at Dermatology Care of Alabama.

Typically, when we see a patient for a skin cancer concern, we assess any risk factors for skin cancer, taking into consideration family history, skin type and other factors. A full body exam allows us to detect any possible skin cancers, even those you may not notice or can see yourself. If there are any skin lesions that appear to be concerning, we perform a biopsy.

Other skin lesions may be actinic keratoses, these are pre-cancerous, and some may become squamous cells. If AKs are detected, youll be encouraged to follow up with regular skin exams.

Dermatology Care of Alabama has on-site in office treatment for basal cell and squamous cells through Superficial Radiation Treatment (SRT). We are pleased to offer SRT, in our Tuscaloosa office and we hope to offer it soon for our patients in Hoover, as well.

SRT treatment provides a non-surgical alternative for the treatment of skin cancers. Patients are able to receive radiation treatments conveniently in our Tuscaloosa office, under the direction of our radiation therapist and our physicians. With SRT there is no surgery, no scarring and no downtime. Each treatment lasts only a few minutes and is spread out over the course of six weeks. A typical treatment cycle requires 22-24 treatments. SRT is a very popular option for patients who are apprehensive about surgical removal procedures, especially on the nose, ears or face.

At Dermatology Care of Alabama, we also make patients aware that caring for the skin is often related to other underlying health concerns and conditions.

Many times, the skin will be the first indicator of a larger health issue. We may have a patient see us for a rash, but that may lead us to discover more a serious systemic disease. Being able to help patients get treatments, but also being able to diagnose what may be a much more serious disease is why we do what we do.

For the best in dermatological care, call us today for an appointment.

Dermatology Care of Alabama

Where: 2321 John Hawkins Parkway, Suite 201 in Hoover and 4960 Rice Mine Road NE, Suite 40 in Tuscaloosa

Call: 205-379-8389 (Hoover), 205-759-1519 (Tuscaloosa)

Hours: Monday-Thursday, 8 a.m. to 5 p.m.; Friday, 8 a.m. to noon.

Web: dermcarealabama.com and dermcarehoover.com

New patients welcome

Continued here:

Dermatology Care of Alabama goes the extra mile to give the best care - Hoover Sun

Dermatology

What to Know About Peptides, the Retinol Alternative Dermatologists Love | SELF – Self

Ask any dermatologist what the best wrinkle-reducing ingredient is and were willing to bet our firstborn theyll say retinoids. But theres a gentler, slightly more under-the-radar alternative out there: Derms also love peptides for their skin-smoothing benefits (namely, their ability to minimize lines without causing irritation). If retinoids like retinol and tretinoin are the Regina George of skin care, then peptides are the Cady Heronmore chill, nicer to your face, but still totally worthy of being the star of the show.

The benefits of peptides are legitimate, with plenty of science to back them up. And while dermatologists often recommend them as a substitute for retinoids, particularly for people who cant tolerate the latter, they also play nicely with most other actives (including, yes, retinoids, as well as vitamin C). In other words, you shouldnt have a problem working them into your routine.

The caveat? Peptides is a surprisingly broad category and shopping for the best products can require a bit more legwork than you might expect. Thats why we asked a few experts to explain exactly what to look for when picking peptide serums and moisturizersand break down the nitty-gritty of what they can do for your skin.

Peptides are short chains of amino acids that are the building blocks of various proteins, David Kim, MD, a board-certified dermatologist at Idriss Dermatology in New York City, tells SELF. They play a key role in a variety of processes throughout your body; when it comes to your skin, peptides are important because they help make up the proteins collagen and elastin. Collagen is like the scaffolding for your skin, giving it support and structure so it stays firm, while elastin keeps it stretchy and, yep, elastic, Dr. Kim says.

Both collagen and elastin production innately start to decrease around your late 20s or early 30s, when signs of aging such as wrinkles and laxity can start to pop up. Thats where peptides come in: They can help counteract some of these effects, he explains. To that point.

Heres where things get a little more complicated. Not all peptides are created equal. As a general rule, theyre used in skin care for their ability to smooth fine lines and wrinkles, Angela Lamb, MD, a board-certified dermatologist and associate professor of dermatology at Mount Sinai in New York City, tells SELF.

Depending on the type of peptides youre talking about, however, they can also have other beneficial effects, including decreasing inflammation and acting as antioxidants, Mona Foad, MD, a board-certified dermatologist in Cincinnati, tells SELF. (There are even antimicrobial peptides that have been shown to have wound-healing properties, though theyre less likely to be used in skin care.)

Topical peptides are typically classified into these four categories, all of which you can find in serums, moisturizers, and the like (albeit some more commonly than others).

Read the original here:

What to Know About Peptides, the Retinol Alternative Dermatologists Love | SELF - Self

Dermatology

Dermatologists Advise Against Taking Bite Of Facial Cream – The Onion

ROSEMONT, ILSaying the product tasted bad despite having an appearance similar to vanilla pudding, the American Academy of Dermatology issued guidelines Wednesday in which it advised against taking a big bite of facial cream. We conducted a few tests and found that while skincare products may look velvety smooth and yummy sometimes, its not a good idea to eat them, because they can be really gross, said Harold Wilmington, a dermatologist who helped devise the new recommendations, describing how he winced and vigorously wiped his tongue with a paper towel the first time he consumed facial cream, which almost made [him] puke even though it smelled nice like coconuts. We tried putting it in the refrigerator to make it cold, like regular pudding, but it didnt hide whatever ingredients are in facial cream that make it taste so bad. Slicing up a banana and tossing it in there didnt help, either. That stuffs pretty awful. Wilmington added that in a pinch it was probably okay to serve facial cream with vanilla wafers, but even then, it might be better to just eat the cookies by themselves.

Little-Known Origins Of Your Favorite Thanksgiving Foods

Continued here:

Dermatologists Advise Against Taking Bite Of Facial Cream - The Onion

Dermatology

Reviewing Common and Prevalent Dermatoses in AAPI Patients – Dermatology Times

Image Credit: naka - stock.adobe.com

May is Asian American and Pacific Islander (AAPI) Heritage Month. Throughout the month, we spotlighted a number of studies and dermatologic concerns faced by members of this patient population, including the influence of fairness cream advertisements, apocrine adenocarcinoma and secondary primary malignancies, melanoma treatment delay, and strides to measure atopic dermatitis.

Below, we recap our headlines from the month of May that spotlight these concerns.

Do you specialize in or have a particular interest in research or caring for dermatologic concerns among AAPI patient populations? If you would like to share your research or experiences with us, email our team at DTEditor@mmhgroup.com.

Topical skin lightening, or "fairness" creams, have gained significantly popularity in sub-continental Asian populations, where fair skin is deemed highly sought after. In this region, these beliefs have become engrained in the culture, with previous historical ties to social status and wealth.1

Despite their popularity and market demand, skin lightening agents may be associated with negative effects on the skin. Furthermore, they have been associated with a predisposition to infections and endocrinologic concerns.2

In the first known study to analyze the content and influence of fairness cream commercials from South Asia, researchers Razi et al found that the vast majority of fairness commercials targeted female consumers and capitalized on the use of celebrities in their advertisement. However, less than half of commercials employed transparency by mentioning specific ingredients in the products.3

Read more here.

Apocrine adenocarcinomas (AA) are rare adnexal tumors of the skin commonly located in regions with high sweat gland density. They can often be aggressive in nature, with metastatic dissemination, often with lymph node invasion, occurring in approximately 30% of patients.4

A study, titled, "Assessment of Secondary Primary Malignancies in Apocrine Adenocarcinoma by Racial Group," was included in a poster, authored by Kripa Ahuja of Eastern Virginia Medical School, at the 2024 Skin of Color Society Scientific Symposium ahead of the American Academy of Dermatology Annual Meeting in San Diego, California, in March.5

The study and poster explored the risk of secondary primary malignancies (SPMs) in patients of different racial demographics, seeking to compare risk and rates of SPMs in patients with skin of color versus White patients. According to Ahuja, data assessing the risk of SPMs in patients with AA and skin of color are limited, as reported cases of AA are most often attributed to White patients.

Read more here.

A 2020 study published in theJournal of the American Academy of Dermatology6 found that while Asian American and Pacific Islander (AAPI) patients have a significantly lower risk of melanoma than White patients, they face poorer outcomes and an overall lowered risk of survival.

In 2023, researchers Fane et al authors a study titled, "Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: A cross-sectional study." The study, published in the Journal of the European Academy of Dermatology and Venereology, found that AAPI patients also face increased odds of treatment delay when it comes to melanoma.7

Read more here.

A recent study in Singapore found that the RECAP tool effectively measures disease control in atopic eczema. It demonstrated strong correlations with the Patient-Oriented Eczema Measure and the Dermatology Life Quality Index, indicating a significant link between symptoms and quality of life. However, the correlation with SCORing Atopic Dermatitis was moderate.

Read more here.

References

Excerpt from:

Reviewing Common and Prevalent Dermatoses in AAPI Patients - Dermatology Times

Dermatology

Prescription Dermatology Therapeutics Market Drivers And Restraints Identified Through SWOT Analysis 2030 – openPR

Prescription Dermatology Therapeutics Market

Prescription Dermatology Therapeutics Market Overview

The market overview of the Prescription Dermatology Therapeutics Market focuses on the specific market characteristics, including elements like industry competition. Comprehensive market revenue predictions are provided for the global, regional, segment, and national levels in the report. The report's sales projections for each region and industry is one of its primary highlights.

For Sample Request Link: https://www.maximizemarketresearch.com/request-sample/36992

Prescription Dermatology Therapeutics Market Report Scope and Research Methodology

The study methodology used a mix of primary and secondary research techniques to compile market data. The primary research techniques, such as questionnaires, interviews, and market observations, would have given the researchers access to first-hand market data, which is usually beneficial. The researchers might have gathered background knowledge and market data by using secondary research techniques including industry studies, business websites, and news articles.

The study examines the Prescription Dermatology Therapeutics Market through a market-focused and commercial analysis that takes into account the market's revenue, financial situation, portfolio, technical advancements, and mergers and acquisitions. This strategy aids in giving a complete picture of the market, which stakeholders, investors, and market participants may use to create investment strategies and marketing strategies.

Prescription Dermatology Therapeutics Market Regional Insights

The report offers an in-depth analysis of the factors influencing growth, limitations, future prospects, and competition within the industry across all regions. The market is classified by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The report also provides a comprehensive overview of the leading countries in each region, along with their respective market forecasts.

Prescription Dermatology Therapeutics Market Segmentation

by Product

Acne and Rosacea Drugs Fungal Infection Drugs Psoriasis Drugs Hyperpigmentation/ Melisma Drugs Skin Cancer Drugs Hair Loss and Hair Removal Drugs Antiaging and Photo Damage Drugs Dermatitis and Seborrhea Drugs

by Distribution Channel

Hospital Pharmacies Retail pharmacies Mail order pharmacies

Sample Request Report Link Details Click Here @ https://www.maximizemarketresearch.com/request-sample/36992

Prescription Dermatology Therapeutics Market Key Players

AbbVie, Inc. Janssen Biotech, Inc. Novartis AG, Amgen, Inc. Celgene Corporation Pfizer, Inc. LEO Pharma A/S Eli Lilly and Company Bausch Health Companies, Inc. Sun Pharmaceuticals Ltd.

To Get More: https://www.maximizemarketresearch.com/market-report/prescription-dermatology-therapeutics-market/36992/

Key questions answered in the Automotive Relay Market are:

What is Prescription Dermatology Therapeutics ? What are the recent industry trends that can be implemented to generate additional revenue streams for Prescription Dermatology Therapeutics Market? Which factors are the lucrative opportunities for the Prescription Dermatology Therapeutics market growth? How is the intervention from regulatory authority is shaping the Prescription Dermatology Therapeutics Market? What growth strategies are the players considering to increase their presence in Prescription Dermatology Therapeutics Market? Who held the largest market share in Prescription Dermatology Therapeutics Market? What is the Prescription Dermatology Therapeutics market size of the dominating region?

Key Offerings:

Past Market Size and Competitive Landscape (2018 to 2022) Past Pricing and price curve by region (2018 to 2022) Market Size, Share, Size & Forecast by different segment | 2022-2029 Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region Market Segmentation - A detailed analysis by segment with their sub-segments and Region Competitive Landscape - Profiles of selected key players by region from a strategic perspective o Competitive landscape - Market Leaders, Market Followers, Regional player o Competitive benchmarking of key players by region PESTLE Analysis PORTER's analysis Value chain and supply chain analysis Legal Aspects of business by region Lucrative business opportunities with SWOT analysis Recommendations

Relate Report Link:

Data Historian Market https://www.maximizemarketresearch.com/market-report/global-data-historian-market/63023/

Global Cloud PBX Market https://www.maximizemarketresearch.com/market-report/global-cloud-pbx-market/62884/

Global Sports Mouth Guard Market https://www.maximizemarketresearch.com/market-report/global-sports-mouth-guard-market/70068/

Global AWS Managed Services Market https://www.maximizemarketresearch.com/market-report/global-aws-managed-services-market/27019/

Global Hemp-based Food Market https://www.maximizemarketresearch.com/market-report/global-hemp-based-food-market/73209/

Global Stationary Fuel Cell Market https://www.maximizemarketresearch.com/market-report/global-stationary-fuel-cell-market/40979/

DC Contractor Market https://www.maximizemarketresearch.com/market-report/dc-contactor-market/146784/

US Fencing Market https://www.maximizemarketresearch.com/market-report/us-fencing-market/21845/

Global Copper Foil Market https://www.maximizemarketresearch.com/market-report/copper-foil-market/122392/

Global Woodworking Machine Market https://www.maximizemarketresearch.com/market-report/global-woodworking-machine-market/95215/

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 sales@maximizemarketresearch.com http://www.maximizemarketresearch.com

About Maximize Market Research:

A versatile market research and consulting firm, Maximize Market Research employs experts from several sectors. Medical device manufacturers, pharmaceutical companies, science and engineering, electronic components, industrial equipment, technology and communication, automobiles, chemical goods and substances, general merchandise, alcoholic beverages, personal care products, and automated systems are a few of the industries we cover. To name a few, we offer client impact studies, technical trend analysis, critical market research, competitive analysis, production and demand analysis, and market-verified industry estimations.

This release was published on openPR.

Link:

Prescription Dermatology Therapeutics Market Drivers And Restraints Identified Through SWOT Analysis 2030 - openPR

Dermatology

What Gen Z Should Know About Sunscreen to Help Protect From Skin Cancer – The New York Times

Two new surveys suggest a troubling trend: Young adults seem to be slacking on sun safety.

In an online survey of more than 1,000 people published this month by the American Academy of Dermatology, 28 percent of 18- to 26-year-olds said they didnt believe suntans caused skin cancer. And 37 percent said they wore sunscreen only when others nagged them about it.

In another poll, published this month by Orlando Health Cancer Institute, 14 percent of adults under 35 believed the myth that wearing sunscreen every day is more harmful than direct sun exposure. While the surveys are too small to capture the behaviors of all young adults, doctors said theyve noticed these knowledge gaps and riskier behaviors anecdotally among their younger patients, too.

To some extent, experts said, this issue isnt unique to the current generation of young adults. Theres a component of young people just being young people, said Dr. Melissa Shive, a dermatologist at UCI Health in Irvine, Calif. One survey conducted between 1986 and 1996 found that then-18- to 24-year-olds (who are now middle-aged) were more likely than older adults to visit tanning booths and get sunburns.

Young adults are often unaware of what sun damage looks like and how best to prevent it, Dr. Shive said. She said she recently saw a young patient who didnt know tan skin and freckles were signs of sun damage. Dr. Heather Rogers, a clinical assistant professor of dermatology at the University of Washington, said more of her young patients now report visiting tanning beds. Ultraviolet rays whether from tanning beds or direct sunlight can damage skin and cause skin cancer, which can be deadly.

Older adults who participated in the recent surveys didnt have perfect sun safety knowledge, either: 17 percent of millennials surveyed by A.A.D. didnt know tanning caused skin cancer, for instance. But on the whole, younger adults most of whom fell into Gen Z, meaning they were born after 1997 were more likely to report believing sun safety myths.

Experts said that Gen Z is uniquely susceptible to misinformation about sunscreen and skin cancer that has proliferated on social media platforms like TikTok. They pointed to posts from influencers who claim incorrectly that sunscreen can cause cancer, or from celebrities who claim that they dont use sunscreen because it interferes with vitamin D absorption. (Years of scientific evidence supports sunscreens benefits in preventing skin cancer, Dr. Shive said.)

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit andlog intoyour Times account, orsubscribefor all of The Times.

Thank you for your patience while we verify access.

Already a subscriber?Log in.

Want all of The Times?Subscribe.

More here:

What Gen Z Should Know About Sunscreen to Help Protect From Skin Cancer - The New York Times

Dermatology

Derm In The News: May 19-25 – Dermatology Times

Neuroscience News: UV Light Increases Appetite But Suppresses Weight Gain

A recent study published in the Journal of Investigative Dermatology has found that exposure to ultraviolet (UV) light can increase appetite while preventing weight gain by affecting hormones and neurotransmitters. Researchers observed that UV exposure in mice led to decreased leptin levels and increased norepinephrine, promoting energy expenditure and preventing weight gain even with increased appetite. Future research will focus on developing safe methods to replicate the beneficial effects of UV exposure without its adverse impacts.

A Northwestern Medicine study, published in JAMA Dermatology, is the first large-scale research examining mental health issues in children with chronic skin conditions. The study found that many children and teens with conditions like acne, eczema, psoriasis, alopecia areata, and vitiligo experience significant stigma and bullying, leading to depression, anxiety, and poor peer relationships. The study, involving 1,671 children and 31 sites, revealed that 73% had experienced stigma, which was linked to a poor quality of life. Researchers also discovered a discrepancy between how children and doctors rated the severity and visibility of the disease.

Top headlines from this week to share with your patients:

Bristol Myers Squibb announced that the FDA has set a new Prescription Drug User Fee Act goal date of December 29, 2024, for the Biologics License Application for the subcutaneous formulation of Opdivo (nivolumab), combined with Halozymes recombinant human hyaluronidase. This application covers all approved adult solid tumor indications for Opdivo, either as monotherapy or in combination with other treatments.

Dermatology Times covered this news! Read more here.

At Viva Technology Paris 2024, LOral will present several innovations under the theme 'Beauty for Each, Powered by Beauty Tech,' emphasizing personalized, inclusive, and responsible beauty. These innovations include advanced skin and hair diagnostics, a GenAI-powered personal beauty assistant, the CREAITECH GenAI Beauty Content Lab to enhance creativity, an infrared light hair dryer, a micro-resurfacing skin care device, and a realistic bioprinted skin platform for research and product testing. The new bioprinted skin technology mimics diverse human skin conditions.

Influencers on TikTok have recently been promoting dangerous health trends, including abandoning sunscreen due to fears about cancer-causing chemicals like benzene. These influencers claim, without evidence, that sunlight does not cause skin cancer and suggest alternatives like coconut oil for sun protection. Dermatology experts have led the conversation against these claims, educating and that the benefits of using sunscreen far outweigh any potential risks.

Have you seen any dermatology headlines this week that we may have missed? Share with us by emailing our team atDTEditor@mmhgroup.com.

See the original post:

Derm In The News: May 19-25 - Dermatology Times

Anatomy

Grey’s Anatomy season 21: Release date speculation, cast news, and latest information – RadioTimes

The recent shorter twentieth season may have had fewer episodes due to the recent WGA and SAG-AFTRA strikes but that does not mean it was short on the drama!

Even with fewer appearances, Dr Meredith Grey (Ellen Pompeo) still had a major storyline as she did covert research into Alzheimer's disease, but she and her co-conspirators faced a huge stumbling block in the final episodes: Dr Catherine Fox (Debbie Allen).

So, with the new season in mind, what lies ahead for Grey's Anatomy season 21 and when can we expect it?

Grey's Anatomy season 21 will air in the US on ABC and Hulu in Fall 2024.

We can likely expect the episodes to premiere in September or October 2024 in line with the show's usual transmission pattern.

The series won't be impacted by industry strikes this time around so we should expect a full-length season.

The following Grey's Anatomy main cast members are expected to return next season.

The main cast will see two departures in the next season. Actor Jake Borelli will return for an exit storyline for long-running character Dr Levi Schmitt, while actress Midori Francis will also be leaving the show following an exit storyline for Dr Mika Yasuda, making her the first of the new generation of interns to leave the series. Both are expected to appear in multiple episodes before they leave next season.

Deadline has also reported that a cost-cutting move will likely see episodic appearances for series veterans reduced in a bid to lower costs, which appears to be the reason for Borelli's exit too.

Additionally, we can likely expect returns for recurring characters including Scott Speedman as Dr Nick Marsh, Debbie Allen as Dr Catherine Fox, Jaicy Elliot as Dr Taryn Helm, Natalie Morales as Dr Monica Beltran, and Jason George as Dr Ben Warren.

According to Deadline, it is expected that George will return to a more prominent role in the show as Ben following the end of the spin-off series Station 19 and Dr Warren's renewed interest in medicine. It remains to be seen if he will be a series regular or recurring character, but Ben is still very much Bailey's loving husband.

Well, there are a number of plot points to continue following the finale of season 20.

Dr Catherine Fox went on a firing spree following multiple clashes, cutting ties with Dr Meredith Grey over her secret Alzheimer's research and then with Meredith's accomplices Dr Amelia Shepherd and Dr Teddy Altman - the latter of whom was fired as Chief of Surgery. Dr Owen Hunt was also fired when he stood up for Teddy when Catherine tried to drop her from a trauma response team to a wildfire.

Meanwhile, the interns were also in a mutiny over the harsh decision made by Dr Fox against Dr Lucas Adams, which did not seem to bother Dr Fox until she faced the potential resignation of Dr Miranda Bailey!

Elsewhere, Dr Richard Webber had also been questioning his career after having a major shaky period following the near-breaking of his sobriety.

Dr Levi Schmitt also considered his career future as he aimed to get on a pediatric medicine fellowship and we know his exit is imminent...

Plus, Dr Jo Wilson discovered she was pregnant with Dr Atticus 'Link' Lincoln's baby - will the pair's family continue to run smoothly?

Finally, romance is in the air for divorc Dr Winston Ndugu and newcomer Dr Monica Beltran, while Dr Mika Yasuda and Dr Jules Millin shared a near-kiss. Where will things go next? Well, given Yasuda's coming exit, it can't be good...

Grey's Anatomy seasons 1 to 20 are available to stream on Disney Plus now sign up to Disney Plus for 7.99 a month or 79.90 a year now. Season 18 is also available on Sky and NOW with new episodes airing on Sky Witness in the UK.

Check out more of our Drama coverage or visit our TV Guide and Streaming Guide to find out what's on. For more from the biggest stars in TV, listen to The Radio Times Podcast.

See the rest here:
Grey's Anatomy season 21: Release date speculation, cast news, and latest information - RadioTimes